Piebaldism and Neurofibromatosis Type 1: Horses of Very Different Colors

Journal of Investigative Dermatology

Volumn 122, Issue 2, 2004, Pages

  Spritz, Richard A ^a   Itin, Peter H ^b   Gutmann, David H ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Dermatology ^*  (Switzerland)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR;

AUTOSOMAL DISORDER; CAFE AU LAIT SPOT; CHROMOSOME 4; EDITORIAL; GENE MUTATION; HUMAN; HYPERPIGMENTATION; MELANOCYTE; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PIEBALDISM; PRIORITY JOURNAL; SKIN PIGMENTATION;

EID: 1442299087     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2004.22235.x     Document Type: Article

References (33)

1. Angelo C, Cianchini G, Grosso MG, Zambruno G, Cavalieri R, Paradisi M: Association of piebaldism and neurofibromatosis type 1 in a girl. Pediatr Dermatol 18:490-493, 2001
2. Ansari MY: Partial albinism. J Indian Med Assoc 34:49, 1960
3. Badache A, Muja N, DeVries GH: Expression of Kit in neurofibromin- deficient human Schwann cells: Role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Oncogene 17:795-800, 1998
4. Breathnach AS, Fitzpatrick TB, Wyllie LMA: Electron microscopy of melanocytes in a case of human piebaldism. J Invest Dermatol 45:2-37, 1965
5. Chang T, McGrae JD, Hashimoto K: Ultrastructural study of two patients with both piebaldism and neurofibromatosis 1. Pediatr Dermatol 10:224-234, 1993
6. Fitzpatrick TB, Martuza RL: Clinical diagnosis of von Recklinghausen's neurofibromatosis. Ann N Y Acad Sci 486:383-385, 1986
7. Fitzpatrick TB, Eldridge R, Hall JG, et al: Problems in diagnosing neurofibromatosis. Adv Neurol 29:245-249, 1981
8. Gatto M, Giannaula R, Micheli F: Piebaldism associated with cancer. Med Cutan Ibero Lat Am 13:545-556, 1985
9. Giebel LB, Spritz RA: Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88:8696-8699, 1991
10. Grüpper C, Prunieras M, Hincky M, Garelly E: Albinisme partiel familial (piebaldisme): Etude ultrastructurale. Ann Dermatol Syphiligr (Paris) 97:267-286, 1970
11. Gutmann DH, Aylsworth A, Carey JC, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:5-57, 1997
12. Hirota S, Nomura S, Asada H, Ito A, Morii E, Kitamura Y: Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues. Arch Pathol Lab Med 117:996-999, 1993
13. Ingram DA, Yan F-C, Travers JB, et al: Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181-187, 2000
14. Jimbow K, Szabo G, Fitzpatrick TB: Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. J Invest Dermatol 61:300-309, 1973
15. Jimbow K, Fitzpatrick TB, Szabo G, Hori Y: Congenital circumscribed hypomelanosis: A characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. J Invest Dermatol 64:50-62, 1975
16. Küster W: Piebaldismus. Hautarzt 38:481-483, 1987
17. Mackool BT, Fitzpatrick TB: Diagnosis of neurofibromatosis by cutaneous examination. Semin Neurol 12:358-363, 1992
18. Martuza RL, Philippe I, Fitzpatrick TB, Zwaan J, Seki Y, Lederman J: Melanin macroglobules as a cellular marker of neurofibromatosis: A quantitative study. J Invest Dermatol 85:347-350, 1985
19. Mosher DB, Fitzpatrick TB: Piebaldism. Arch Dermatol 124:364-365, 1988
20. Nakagawa H, Hori Y, Sato S, Fitzpatrick TB, Martuza RL: The nature and origin of the melanin macroglobule. J Invest Dermatol 83:134-139, 1984
21. National Institutes of Health Consensus Development Conference: Neurofibromatosis: Conference statement. Arch Neurol 45:575-578, 1988
22. Riccardi VM: Piebaldism and neurofibromatosis 1. Pediatric Dermatol 10:288, 1993
23. Ryan JJ, Klein KA, Neuberger TJ, et al: Role for the stem cell factor/ KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res 37:415-432, 1994
24. Sánchez-Martín M, Pérez-Losada J, Rodríguez-García A, et al: Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am J Med Genet 122A: 125-132, 2003
25. Selmanowitz VJ, Rabionowitz AD, Orentreich N, Wenk E: Pigmentary correction of piebaldism by autografts. I. Procedures and clinical findings. J Dermatol Surg Oncol 3:615-622, 1977
26. Smith D, Schultz J: Partial albinism. Arch Dermatol 71:468-470, 1955
27. Spritz RA: Molecular basis of human piebaldism. J Invest Dermatol 103 (Suppl.):137S-140S, 1994
28. Spritz RA: Genetic hypomelanoses: Disorders characterized by congenital depigmentation. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P (eds). The Pigmentary System. New York: Oxford University Press, 1998
29. Spritz RA, Holmes SA, Itin P, Küster W: Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. J Invest Dermatol 101:22-25, 1993
30. Syrris P, Malik NM, Murday VA, Patton MA, Carter ND, Hughes HE, Metcalfe K: Three novel mutations of the proto-oncogene KIT cause human piebaldism. Am J Med Genet 95:79-81, 2000
31. Tay YK: Neurofibromatosis 1 and piebaldism: A case report. Dermatology 197:401-502, 1998
32. Viskochil D, Buchberg AM, Xu G, et al: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192, 1990
33. Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181-186, 1990